Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Rev. neurol. (Ed. impr.) ; 61(4): 167-182, 16 ago., 2015. ilus, tab
Article in Spanish | IBECS | ID: ibc-142327

ABSTRACT

El Grupo de Especial Interés en el Trastorno por Déficit de Atención/Hiperactividad (GEITDAH) presenta en este artículo un consenso de expertos de toda España sobre los trastornos de conducta en niños y adolescentes. A partir del trabajo inicial del equipo de la Unidad de Paidopsiquiatría del Hospital Quirón-Teknon de Barcelona, se han consensuado aspectos básicos que podrían ser el punto de partida para futuros consensos. Ha sido también objetivo prioritario del trabajo actualizar en los trastornos de conducta en niños y adolescentes los criterios del Manual diagnóstico y estadístico de los trastornos mentales, quinta edición, y su comorbilidad con el trastorno por déficit de atención/hiperactividad (AU)


In this paper, the Special Interest Group on Attention Deficit Hyperactivity Disorder (GEITDAH, from its name in Spanish) presents a consensus reached by experts from all over Spain on conduct disorders in children and adolescents. Following the initial work by the team at the Pedopsychiatry Unit at the Quirón-Teknon Hospital in Barcelona, agreements have been reached on a number of basic aspects that could be the starting point for future consensuses. A top priority aim of the work was also to update the criteria in the Diagnostic and statistical manual of mental disorders, fifth edition, for conduct disorders in children and adolescents, together with their comorbidity with attention deficit hyperactivity disorder (AU)


Subject(s)
Child , Female , Humans , Male , Child Behavior Disorders , Attention Deficit and Disruptive Behavior Disorders/diagnosis , Attention Deficit and Disruptive Behavior Disorders/epidemiology , Attention Deficit and Disruptive Behavior Disorders/etiology , Attention Deficit and Disruptive Behavior Disorders/therapy , Social Behavior Disorders/diagnosis , Social Behavior Disorders/epidemiology , Social Behavior Disorders/etiology , Social Behavior Disorders/therapy , Epidemiological Monitoring/trends , Attention Deficit Disorder with Hyperactivity , Antisocial Personality Disorder , Parent-Child Relations , Violence , Self Concept , Attitude , Education , Risk Factors , Comorbidity , Spain/epidemiology
2.
Rev Neurol ; 61(4): 167-82, 2015 Aug 16.
Article in Spanish | MEDLINE | ID: mdl-26204088

ABSTRACT

In this paper, the Special Interest Group on Attention Deficit Hyperactivity Disorder (GEITDAH, from its name in Spanish) presents a consensus reached by experts from all over Spain on conduct disorders in children and adolescents. Following the initial work by the team at the Pedopsychiatry Unit at the Quiron-Teknon Hospital in Barcelona, agreements have been reached on a number of basic aspects that could be the starting point for future consensuses. A top priority aim of the work was also to update the criteria in the Diagnostic and statistical manual of mental disorders, fifth edition, for conduct disorders in children and adolescents, together with their comorbidity with attention deficit hyperactivity disorder.


TITLE: Consenso del GEITDAH sobre los trastornos de conducta en niños y adolescentes.El Grupo de Especial Interes en el Trastorno por Deficit de Atencion/Hiperactividad (GEITDAH) presenta en este articulo un consenso de expertos de toda España sobre los trastornos de conducta en niños y adolescentes. A partir del trabajo inicial del equipo de la Unidad de Paidopsiquiatria del Hospital Quiron-Teknon de Barcelona, se han consensuado aspectos basicos que podrian ser el punto de partida para futuros consensos. Ha sido tambien objetivo prioritario del trabajo actualizar en los trastornos de conducta en niños y adolescentes los criterios del Manual diagnostico y estadistico de los trastornos mentales, quinta edicion, y su comorbilidad con el trastorno por deficit de atencion/hiperactividad.


Subject(s)
Conduct Disorder , Adolescent , Adolescent Behavior , Aggression , Antisocial Personality Disorder/diagnosis , Antisocial Personality Disorder/epidemiology , Attention Deficit Disorder with Hyperactivity/epidemiology , Attention Deficit and Disruptive Behavior Disorders/diagnosis , Attention Deficit and Disruptive Behavior Disorders/epidemiology , Authoritarianism , Child , Child Behavior , Child Behavior Disorders/diagnosis , Child, Preschool , Combined Modality Therapy , Comorbidity , Conduct Disorder/diagnosis , Conduct Disorder/epidemiology , Conduct Disorder/etiology , Conduct Disorder/psychology , Conduct Disorder/therapy , Crime , Diagnosis, Differential , Diagnostic and Statistical Manual of Mental Disorders , Executive Function , Humans , Infant , Parent-Child Relations , Parenting , Psychiatric Status Rating Scales , Psychotherapy/methods , Psychotropic Drugs/therapeutic use , Teaching/methods , Violence
3.
Rev. psiquiatr. infanto-juv ; 29(4): 17-22, 2012. graf
Article in Spanish | IBECS | ID: ibc-186052

ABSTRACT

El grupo de especial interés en TDAH (GEITADH) expone en este artículo su consenso sobre algoritmos de derivación en la asistencia para el paciente afecto de TDAH. Es un diseño sencillo realizado por un amplio número de profesionales de toda España con el objetivo de poder ser adaptado a necesidades asistenciales locales. Se revisan también otros algoritmos con influencia nacional


The Spanish Especial Interest Group on ADHD (GEITDAH) presents in this article its consensus on pathways for attending ADHD patients. This is a clear and simple consensus in order to facilitate the development of local algoritms inspired on it. Some ADHD algorithms used in the Spanish Health Services are reviewed


Subject(s)
Humans , Attention Deficit Disorder with Hyperactivity/diagnosis , Symptom Assessment/methods , Algorithms , Mass Screening/methods , Referral and Consultation , Diagnostic Errors/prevention & control , Professional Training , Practice Patterns, Physicians'
4.
Rev. clín. med. fam ; 1(6): 270-276, feb. 2007. tab
Article in Es | IBECS | ID: ibc-056209

ABSTRACT

La depresión Mayor (DM) se define como el estado de ánimo depresivo o irritable casi todos los días y durante la mayor parte del día, durante más de dos semanas. Este trastorno altera el desarrollo normal del niño a adolescente, generando una discapacidad de sus funciones sociales, escolares y emocionales. Ha sido un tema muy controvertido no aceptándose su existencia antes de la adolescencia tardía hasta ser reconocida como entidad propia en edades tempranas. Es similar a la del adulto variando enormemente la clínica en función de las diferentes etapas del desarrollo de niño. Su prevalencia es de un 2% en niños y un 4-8% en adolescentes, aumentando con la edad, y con claras diferencias por sexos después de la pubertad. Existe escasa evidencia en niños y adolescentes en lo que se refiere al tratamiento, la mayoría basados en la experiencia clínica o en extrapolaciones de estudios en adultos. En el tratamiento farmacológico son de elección los inhibidores selectivos de recaptación de la serotonina (ISRS), siendo la fluoxetina el único antidepresivo autorizado en EEUU en niños y adolescentes. Recientemente, en España, se ha ampliado la indicación de fluoxetina a niños mayores de 8 años y adolescentes con depresión severa-moderada que no responden a psicoterapia. Todos los estudios publicados basan su abordaje terapéutico en un tratamiento psicofarmacológico (AU)


Major depression (MD) is defined as a depressed or irritable mood almost every day for most of the day for more than two weeks. This disorder effects the normal development of a child to an adolescent, causing social, educational and emotional disabilities. This has been a very controversial issue, viewpoints ranging from not being accepted as occurring before late adolescence to being a recognised entity in younger children. It is similar to that in adults and the clinical picture varies enormously depending on the different stages of the child’s development. Its prevalence is 2% in children and 4-8% in adolescents, increasing with age, and there is a clear difference as regards gender after puberty. There is very little evidence of treatment in children and adolescents, most treatments are based on clinical experience or extrapolations of studies in adults. Selective serotonin reuptake inhibitors (SSRI) is the pharmacological treatment of choice, fluoxetine being the only antidepressant drug authorised in the USA for children and adolescents. Recently, in Spain, the use of fluoxetine has been extended to children over 8 years and adolescents with severe to moderate depression who do not respond to psychotherapy. All published studies base their therapeutic approach on psychopharmacological treatment (AU)


Subject(s)
Male , Female , Child , Adolescent , Humans , Depressive Disorder/psychology , Adolescent Behavior/psychology , Child Behavior/psychology , Depressive Disorder/diagnosis , Depressive Disorder/drug therapy , Psychotherapy/methods , Selective Serotonin Reuptake Inhibitors/pharmacology , Fluoxetine/pharmacology , Fluoxetine/therapeutic use , Comorbidity
SELECTION OF CITATIONS
SEARCH DETAIL
...